Skip to content
10-Q

Quarterly Report

EXOZYMES INC. EXOZ

0001493152-26-023035

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 14, 2026 8.48M sh
Shares Diluted Q1 2026 · Mar 31, 2026 8.46M sh
Shares Diluted Q1 2026 · Mar 31, 2025 8.37M sh
Capex Q1 2026 · Mar 31, 2026 $57.6K
Capex Q1 2026 · Mar 31, 2025 $31.05K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.52M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.13M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.44M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3.04M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.53M
Stockholders Equity Q1 2026 · Dec 31, 2025 $3.4M
Stockholders Equity Q1 2026 · Mar 31, 2025 $8.88M
Stockholders Equity Q1 2026 · Dec 31, 2024 $10.42M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.58M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.57M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.49M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.57M
Current Assets Q1 2026 · Mar 31, 2026 $2.09M
Current Assets Q1 2026 · Dec 31, 2025 $3.94M
Total Assets Q1 2026 · Mar 31, 2026 $4.02M
Total Assets Q1 2026 · Dec 31, 2025 $5.97M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.28
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.22
Eps Basic Q1 2026 · Mar 31, 2026 −$0.28
Eps Basic Q1 2026 · Mar 31, 2025 −$0.22
Sga Expense Q1 2026 · Mar 31, 2026 $1.27M
Sga Expense Q1 2026 · Mar 31, 2025 $1.38M
Rd Expense Q1 2026 · Mar 31, 2026 $1.12M
Rd Expense Q1 2026 · Mar 31, 2025 $575.02K
Net Income Q1 2026 · Mar 31, 2026 −$2.37M
Net Income Q1 2026 · Mar 31, 2025 −$1.86M
Operating Income Q1 2026 · Mar 31, 2026 −$2.39M
Operating Income Q1 2026 · Mar 31, 2025 −$1.95M